Digoxin and Elmiron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Digoxin (digoxin) and Elmiron (pentosan polysulfate sodium). Common drug interactions include drug ineffective among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Digoxin and Elmiron. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 93,740 Digoxin users. Check the latest studies of Digoxin.

What is Elmiron?

Elmiron has active ingredients of pentosan polysulfate sodium. It is often used in interstitial cystitis (ic). eHealthMe is studying from 10,215 Elmiron users. Check the latest studies of Elmiron.



On Aug, 01, 2026

17 people who take Digoxin and Elmiron together, and have interactions are studied.

Digoxin and Elmiron drug interactions.

What are the common drug interactions of Digoxin and Elmiron, by gender? *:

female:

  1. Drug ineffective
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Pain
  4. Constipation
  5. Contusion (a type of hematoma of tissue in which capillaries)
  6. Diarrhoea
  7. Fungal infection
  8. Gastrointestinal tract irritation
  9. Anaemia (lack of blood)
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints)

male:

  1. Anaemia (lack of blood)
  2. Chest pain
  3. Colonoscopy
  4. Dyspnoea (difficult or laboured respiration)
  5. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  6. Pneumonia
  7. Thrombosis (formation of a blood clot inside a blood vessel)
  8. Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))

What are the common drug interactions of Digoxin and Elmiron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Red blood cell count decreased
  2. Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
  3. Thyroid cyst
  4. Thyroid mass
  5. Vasoconstriction (constriction of blood vessels, which increases blood pressure)
  6. Volume blood decreased

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Obstructive airways disorder (a progressive disease that makes it hard to breathe)
  5. Renal failure (kidney dysfunction)
  6. Somnolence (a state of near-sleep, a strong desire for sleep)

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Anaemia (lack of blood)
  3. Blood magnesium decreased
  4. Blood potassium decreased
  5. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  6. Colonoscopy
  7. Cough
  8. Dizziness
  9. Drug ineffective
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 23.53%
  2. Cystitis Interstitial (unknown cause characterized by bladder pain): 4 people, 23.53%
  3. High Blood Cholesterol: 4 people, 23.53%
  4. Cardiac Disorder: 3 people, 17.65%
  5. Bladder Disorder: 2 people, 11.76%
  6. Depression: 2 people, 11.76%
  7. Urinary Tract Infection: 1 person, 5.88%
  8. Dry Eyes (lack of adequate tears): 1 person, 5.88%
  9. Genitourinary Tract Neoplasm (genitourinary tract cancer): 1 person, 5.88%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Digoxin and Elmiron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Digoxin and Elmiron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Digoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Elmiron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Digoxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elmiron and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on digoxin and pentosan polysulfate sodium (the active ingredients of Digoxin and Elmiron, respectively), and Digoxin and Elmiron (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: